Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Rising to the metastatic breast cancer challenge: current and future policy responses

This report highlights the diversity of challenges that people with MBC face around the world. It further identifies priorities for policymakers, advocacy organisations, health system administrators and other key stakeholders to improve the quality of life for individuals with MBC. Key takeaways and priorities identified in this research include:

Three strategies for achieving inclusive healthcare for all

Investing in health means investing in people and communities

Infographic | Enhancing patient-centred approaches to optimise early-breast cancer care in New Zealand

Video | Enhancing patient-centred approaches to optimise early-breast cancer care in New Zealand

is a research report by Economist Impact examining the existing breast cancer care pathway in New Zealand and the factors that help or hinder the goal of achieving optimal patient-centred c

Neglected People, Neglected Diseases: Towards Elimination of Lymphatic Filariasis and Onchocerciasis in Sub Saharan Africa

The World Health Organisation (WHO) describes neglected tropical diseases (NTDs) as “ancient diseases of poverty that impose a devastating human, social and economic burden on more than 1 bn people worldwide, predominantly in tropical and subtropical areas among the most vulnerable, marginalised populations.”">[1] NTDs are not neglected because they are insignificant, NTDs are neglected because they are insignificant to the affluent.

A Conversation with Jens Wandel

Sarah Aleyan, global health manager at Economist Impact and Rory Meryon, policy analyst at Economist Impact, sat down with Acting Executive Director of UNOPS, Jens Wandel to discuss his views on the topic of healthcare investments and the value of multi-sectoral partnerships.

Roche and The Economist - Overview of the partnership

Roche and The Economist have worked together over more than 15 years to highlight important challenges faced by health systems. From common cancers, disabling conditions and rare, hard-to-diagnose diseases, Roche has supported the drive to make progress in many different countries.

Harnessing innovation in bleeding disorders

Centred on the insights of experts based in Europe and North America (drawn together in workshops and one-to-one interviews), the report focuses on past, present and future innovations in the treatment and management of rare, inherited bleeding disorders, and where these innovations have been and can be utilised to address current unmet health needs in patients. It focuses on the three most common of these bleeding disorders—haemophilia A, haemophilia B and von Willebrand disease (vWD).

Do no harm: Healthcare professionals address sustainability and climate change

In a survey of hospital doctors and nurses in France, Germany and the UK, many agreed they need to better prepare patients and adapt their healthcare systems to be more sustainable.

Executive summary

Healthcare professionals (HCPs) are actively treating an increasing number of patients affected by climate change factors. But healthcare facilities, activities and supply chains are a large contributor to climate change, unintentionally reinforcing the very problems they aim to solve. In total, healthcare represents 4-5% of total global carbon emissions.

Enhancing patient-centred approaches to optimise early-breast cancer care in New Zealand

New Zealand is amongst the countries with the highest prevalence of breast cancer, affecting one in nine women, and more than 600 deaths every year. The incidence rate exceeds the OECD average and is second only to Australia. According to the WHO New Zealand Cancer profile, the total breast cancer cases per year are expected to increase by 31% and reach 4,584 by 2040 from 3,504 in 2018.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week